Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-20

Clinical Trial Update: The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection. [NA]

View source ↗

Summary

A clinical trial sponsored by Lo.Li.Pharma s.r.l. is evaluating whether a combination of epigallocatechin gallate (EGCG), folic acid, and vitamin B12 can preven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EGCG (epigallocatechin gallate)
  • Vitamin B12 (cobalamin)
  • folic acid (folic acid)

Snippet

Sponsor: Lo.Li.Pharma s.r.l | Conditions: HPV Infection | NA | Status: RECRUITING